US Stock MarketDetailed Quotes

XTLB XTL Biopharmaceuticals

Watchlist
  • 1.740
  • +0.080+4.82%
Close Feb 14 16:00 ET
15.34MMarket Cap-8.70P/E (TTM)

XTL Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-22.03%1.72M
-33.45%1.59M
-18.67%2.34M
-46.09%2.01M
-46.09%2.01M
-49.72%2.21M
-53.78%2.38M
3.01%2.88M
-39.27%3.72M
-39.27%3.72M
-Cash and cash equivalents
-43.72%820K
-62.62%594K
-43.91%1.07M
-33.09%1.4M
-33.09%1.4M
-34.55%1.46M
-32.27%1.59M
-31.81%1.9M
-29.47%2.09M
-29.47%2.09M
-Short-term investments
20.16%900K
24.94%992K
30.76%1.27M
-62.81%605K
-62.81%605K
-65.34%749K
-71.74%794K
--972K
-48.48%1.63M
-48.48%1.63M
Receivables
--140K
--304K
--150K
-59.15%29K
-59.15%29K
----
----
----
--71K
--71K
-Accounts receivable
--140K
----
----
----
----
----
----
----
----
----
-Loans receivable
----
--304K
--150K
----
----
----
----
----
----
----
-Other receivables
----
----
----
-59.15%29K
-59.15%29K
----
----
----
--71K
--71K
Other current assets
64.94%127K
8.47%128K
-10.61%59K
-21.43%11K
-21.43%11K
-40.77%77K
-46.36%118K
-98.09%66K
-12.50%14K
-12.50%14K
Total current assets
-12.97%1.99M
-19.31%2.02M
-13.39%2.55M
-46.24%2.05M
-46.24%2.05M
-49.46%2.28M
-53.48%2.5M
-52.85%2.94M
-38.98%3.81M
-38.98%3.81M
Non current assets
Net PPE
--217K
----
----
----
----
----
----
----
----
----
Goodwill and other intangible assets
1,762.11%7.08M
0.00%380K
0.00%380K
0.00%380K
0.00%380K
0.00%380K
0.00%380K
--380K
0.00%380K
0.00%380K
-Other intangible assets
----
----
----
0.00%380K
0.00%380K
----
----
----
0.00%380K
0.00%380K
Total non current assets
1,819.21%7.29M
0.00%380K
0.00%380K
0.00%380K
0.00%380K
0.00%380K
-0.26%380K
-0.26%380K
-0.26%380K
-0.26%380K
Total assets
248.48%9.28M
-16.77%2.4M
-11.86%2.93M
-42.04%2.43M
-42.04%2.43M
-45.62%2.66M
-49.96%2.88M
-49.83%3.32M
-36.75%4.19M
-36.75%4.19M
Liabilities
Current liabilities
Payables
241.98%554K
1.23%165K
-7.47%223K
-50.00%1K
-50.00%1K
--162K
--163K
--241K
0.00%2K
0.00%2K
-accounts payable
241.98%554K
1.23%165K
-7.47%223K
-50.00%1K
-50.00%1K
--162K
--163K
--241K
0.00%2K
0.00%2K
Current accrued expenses
----
----
----
10.81%205K
10.81%205K
----
----
----
-19.21%185K
-19.21%185K
Current debt and capital lease obligation
--168K
----
----
----
----
----
----
----
----
----
-Current debt
--168K
----
----
----
----
----
----
----
----
----
Other current liabilities
--1.75M
----
----
----
----
----
----
----
----
----
Current liabilities
1,422.84%2.47M
1.23%165K
-7.47%223K
10.16%206K
10.16%206K
5.88%162K
-5.23%163K
-7.31%241K
-19.05%187K
-19.05%187K
Non current liabilities
Non current deferred liabilities
--331K
----
----
----
----
----
----
----
----
----
Derivative product liabilities
--765K
----
----
----
----
----
----
----
----
----
Total non current liabilities
--1.1M
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
2,099.38%3.56M
1.23%165K
-7.47%223K
10.16%206K
10.16%206K
5.88%162K
-15.98%163K
-68.98%241K
-85.45%187K
-85.45%187K
Shareholders'equity
Share capital
63.87%23.14M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
--14.12M
0.00%14.12M
0.00%14.12M
-common stock
63.87%23.14M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
--14.12M
0.00%14.12M
0.00%14.12M
Retained earnings
-0.51%-158.77M
-0.31%-158.23M
-0.24%-157.76M
-1.14%-158.25M
-1.14%-158.25M
-1.44%-157.97M
-1.84%-157.75M
---157.39M
-0.86%-156.47M
-0.86%-156.47M
Paid-in capital
-3.42%141.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
--146.33M
0.00%146.33M
0.00%146.33M
Gains losses not affecting retained earnings
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
--20K
0.00%20K
0.00%20K
Total stockholders'equity
128.59%5.72M
-17.84%2.23M
-12.20%2.71M
-44.49%2.22M
-44.49%2.22M
-47.28%2.5M
-51.14%2.72M
-47.28%3.08M
-25.01%4M
-25.01%4M
Total equity
128.59%5.72M
-17.84%2.23M
-12.20%2.71M
-44.49%2.22M
-44.49%2.22M
-47.28%2.5M
-51.14%2.72M
-47.28%3.08M
-25.01%4M
-25.01%4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -22.03%1.72M-33.45%1.59M-18.67%2.34M-46.09%2.01M-46.09%2.01M-49.72%2.21M-53.78%2.38M3.01%2.88M-39.27%3.72M-39.27%3.72M
-Cash and cash equivalents -43.72%820K-62.62%594K-43.91%1.07M-33.09%1.4M-33.09%1.4M-34.55%1.46M-32.27%1.59M-31.81%1.9M-29.47%2.09M-29.47%2.09M
-Short-term investments 20.16%900K24.94%992K30.76%1.27M-62.81%605K-62.81%605K-65.34%749K-71.74%794K--972K-48.48%1.63M-48.48%1.63M
Receivables --140K--304K--150K-59.15%29K-59.15%29K--------------71K--71K
-Accounts receivable --140K------------------------------------
-Loans receivable ------304K--150K----------------------------
-Other receivables -------------59.15%29K-59.15%29K--------------71K--71K
Other current assets 64.94%127K8.47%128K-10.61%59K-21.43%11K-21.43%11K-40.77%77K-46.36%118K-98.09%66K-12.50%14K-12.50%14K
Total current assets -12.97%1.99M-19.31%2.02M-13.39%2.55M-46.24%2.05M-46.24%2.05M-49.46%2.28M-53.48%2.5M-52.85%2.94M-38.98%3.81M-38.98%3.81M
Non current assets
Net PPE --217K------------------------------------
Goodwill and other intangible assets 1,762.11%7.08M0.00%380K0.00%380K0.00%380K0.00%380K0.00%380K0.00%380K--380K0.00%380K0.00%380K
-Other intangible assets ------------0.00%380K0.00%380K------------0.00%380K0.00%380K
Total non current assets 1,819.21%7.29M0.00%380K0.00%380K0.00%380K0.00%380K0.00%380K-0.26%380K-0.26%380K-0.26%380K-0.26%380K
Total assets 248.48%9.28M-16.77%2.4M-11.86%2.93M-42.04%2.43M-42.04%2.43M-45.62%2.66M-49.96%2.88M-49.83%3.32M-36.75%4.19M-36.75%4.19M
Liabilities
Current liabilities
Payables 241.98%554K1.23%165K-7.47%223K-50.00%1K-50.00%1K--162K--163K--241K0.00%2K0.00%2K
-accounts payable 241.98%554K1.23%165K-7.47%223K-50.00%1K-50.00%1K--162K--163K--241K0.00%2K0.00%2K
Current accrued expenses ------------10.81%205K10.81%205K-------------19.21%185K-19.21%185K
Current debt and capital lease obligation --168K------------------------------------
-Current debt --168K------------------------------------
Other current liabilities --1.75M------------------------------------
Current liabilities 1,422.84%2.47M1.23%165K-7.47%223K10.16%206K10.16%206K5.88%162K-5.23%163K-7.31%241K-19.05%187K-19.05%187K
Non current liabilities
Non current deferred liabilities --331K------------------------------------
Derivative product liabilities --765K------------------------------------
Total non current liabilities --1.1M--0--0--0--0--0--0--0--0--0
Total liabilities 2,099.38%3.56M1.23%165K-7.47%223K10.16%206K10.16%206K5.88%162K-15.98%163K-68.98%241K-85.45%187K-85.45%187K
Shareholders'equity
Share capital 63.87%23.14M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M--14.12M0.00%14.12M0.00%14.12M
-common stock 63.87%23.14M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M--14.12M0.00%14.12M0.00%14.12M
Retained earnings -0.51%-158.77M-0.31%-158.23M-0.24%-157.76M-1.14%-158.25M-1.14%-158.25M-1.44%-157.97M-1.84%-157.75M---157.39M-0.86%-156.47M-0.86%-156.47M
Paid-in capital -3.42%141.33M0.00%146.33M0.00%146.33M0.00%146.33M0.00%146.33M0.00%146.33M0.00%146.33M--146.33M0.00%146.33M0.00%146.33M
Gains losses not affecting retained earnings 0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K--20K0.00%20K0.00%20K
Total stockholders'equity 128.59%5.72M-17.84%2.23M-12.20%2.71M-44.49%2.22M-44.49%2.22M-47.28%2.5M-51.14%2.72M-47.28%3.08M-25.01%4M-25.01%4M
Total equity 128.59%5.72M-17.84%2.23M-12.20%2.71M-44.49%2.22M-44.49%2.22M-47.28%2.5M-51.14%2.72M-47.28%3.08M-25.01%4M-25.01%4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.34%
NVIDIA
NVDA
+2.63%
Cisco
CSCO
+1.61%
Netflix
NFLX
+1.43%
Apple
AAPL
+1.27%

Unlock the Full List